These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21999920)

  • 1. Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS).
    Lifford KJ; Fraser L; Rosenthal AN; Rogers MT; Lancastle D; Phelps C; Watson EK; Clements A; Iredale R; Jacobs I; Menon U; Brain KE
    Gynecol Oncol; 2012 Jan; 124(1):158-63. PubMed ID: 21999920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological outcomes of familial ovarian cancer screening: no evidence of long-term harm.
    Brain KE; Lifford KJ; Fraser L; Rosenthal AN; Rogers MT; Lancastle D; Phelps C; Watson EK; Clements A; Menon U
    Gynecol Oncol; 2012 Dec; 127(3):556-63. PubMed ID: 22943881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of women's experiences of familial ovarian cancer screening.
    Lifford KJ; Clements A; Fraser L; Lancastle D; Brain K;
    Psychooncology; 2013 Nov; 22(11):2576-84. PubMed ID: 23801640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.
    Brain K; Gravell C; France E; Fiander A; Gray J
    Gynecol Oncol; 2004 Mar; 92(3):905-13. PubMed ID: 14984959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological adjustment to familial-genetic risk assessment for ovarian cancer: predictors of nonadherence to surveillance recommendations.
    Ritvo P; Irvine J; Robinson G; Brown L; Murphy KJ; Matthew A; Rosen B
    Gynecol Oncol; 2002 Jan; 84(1):72-80. PubMed ID: 11748980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk perceptions and distress among women attending a familial ovarian cancer clinic.
    Cull A; Fry A; Rush R; Steel CM
    Br J Cancer; 2001 Mar; 84(5):594-9. PubMed ID: 11237377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Lubsen-Brandsma L; Massuger LF; Mourits MJ; Gaarenstroom KN; van Dorst EB; van der Putten H; Boonstra H; Aaronson NK
    J Clin Oncol; 2007 Jan; 25(3):301-7. PubMed ID: 17235045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illness representations and distress in women undergoing screening for familial ovarian cancer.
    Lancastle D; Brain K; Phelps C
    Psychol Health; 2011 Dec; 26(12):1659-77. PubMed ID: 21736431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer.
    Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander M; Tucker K
    Med Decis Making; 2006; 26(4):360-72. PubMed ID: 16855125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
    BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
    Antill Y; Reynolds J; Young MA; Kirk J; Tucker K; Bogtstra T; Wong S; Dudding T; Di Iulio J; Phillips KA
    Eur J Cancer; 2006 Mar; 42(5):621-8. PubMed ID: 16434187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.
    Bresser PJ; Seynaeve C; Van Gool AR; Niermeijer MF; Duivenvoorden HJ; van Dooren S; van Geel AN; Menke-Pluijmers MB; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):95-103. PubMed ID: 17095208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family physicians' perspectives on ovarian cancer.
    Gray RE; Chart P; Carroll JC; Fitch MI; Cloutier-Fisher D
    Cancer Prev Control; 1999 Feb; 3(1):61-7. PubMed ID: 10474754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancer.
    Ritvo P; Robinson G; Irvine J; Brown L; Murphy KJ; Stewart DS; Styra R; Wang C; Mullen M; Cole D; Rosen B
    Gynecol Oncol; 1999 Sep; 74(3):331-7. PubMed ID: 10479489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospectively detected cancer in familial breast/ovarian cancer screening.
    Dørum A; Heimdal K; Løvslett K; Kristensen G; Hansen LJ; Sandvei R; Schiefloe A; Hagen B; Himmelmann A; Jerve F; Shetelig K; Fjaerestad I; Tropé C; Møller P
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):906-11. PubMed ID: 10577622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.